KnowTheStock
Log inCreate free account

Abbott Laboratories

ABT
S&P 500Surgical and Medical Instrument Manufacturing · NEW YORK STOCK EXCHANGE INC.
$92.71last close · market cap 161.59 Billion
Compare with…
58.1SCORE / 100
Our verdictHOLDModerate Growth and StableQtr Ending 2026-06-30

Why Hold

Balance sheet is strong; income statement and cash flow are moderate.

Next earnings: 2026-10-21 (BMO), EPS Forecast: $1.43

What is strong
  • Net Margin is 11.59%
  • Debt Ratio is 0.16
  • Total Debt to Total Assets Ratio is 0.3
What to watch
  • Revenue Growth is 8.06%
  • Operating Income Growth is -2.25%
  • Net Income Growth is -61.15%
  • Earnings Per Share (EPS) Growth is -60.98%
  • Current Asset to Current Liability Ratio is 1.38
  • Current Debt to Net Income Ratio is 3.34
  • Cash from Operations Growth is 9.6%
  • Capital Expenditure is High
  • Net Increase in Cash is Negative

What changed

Score by quarter

Downgraded from Buy to Hold in the Mar 2026 quarter: 66.2 → 59.6 (-6.6). This quarter: -1.4.

4050607080Sep 2022Jun 2026

What the score is made of

Income statement56.5 -1.1
Balance sheet65.7 +0.0
Cash flow49.7 -5.1

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)46.59 Billion8.06 % growth
EPS3.11-60.98 % growth
Profit margin11.59 %Profit per $1 of sales
P-E ratio—Not available
Market cap161.59 BillionShares × price
Debt-equity ratio0.64Leverage
Dividend2.44Per share, annual
Next earnings2026-10-21BMO · EPS forecast $1.43
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Abbott Laboratories

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.

Employees
115,000
Sector
Manufacturing
Exchange
NEW YORK STOCK EXCHANGE INC.
abbott.com

Similar stocks

Loading…